Protagonist Therapeutics, Inc
PTGXCIK 0001377121 · Pharmaceutical Preparations · Nasdaq
- Protagonist Therapeutics Inc (until 2013-06-11)
- Protagonist Inc (until 2006-09-28)
Revenue (TTM)
—
Q1 Apr 2026
Net Income (TTM)
−$81.98M
−147.3% YoY
Q1 Apr 2026
EPS Diluted (TTM)
−$1.31
−148.5% YoY
Q1 Apr 2026
Gross Margin
—
Q1 Apr 2026
Operating Margin
—
Q1 Apr 2026
Net Margin
—
Q1 Apr 2026
Free Cash Flow (TTM)
$13.63M
Q1 Apr 2026
Cash
$193.71M
Q1 Apr 2026
Total Debt
$9.83M
Q1 Apr 2026
Shares Outstanding
64.31M sh
Q1 Apr 2026
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.
Balance Sheet
Cash vs Debt
Latest news
All news →-
Moderate Neutral
Protagonist Therapeutics Adopts 2026 Equity Incentive Plan
Stockholders approved a new equity compensation plan that replaces the company's 2016 plan and sets terms for stock and cash awards to employees, directors, and...